EP3496743
Samsetningar og aðferðir til að meðhöndla krabbamein með arginíneyðingu og ónæmiskrabbameinslyfjum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.9.2017EP published:
9.2.2022EP application number:
17840420.8
EP translation filed:
23.3.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
7.9.2037Expiry date:
7.9.2026Next due date:
30.9.2026
Title in English:
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ARGININE DEPLETION AND IMMUNO ONCOLOGY AGENTSLanguage of the patent:
English
Timeline
Today
8.9.2017EP application
9.2.2022EP Publication
23.3.2022Translation submitted
15.5.2022Registration published
7.9.2026Expires
Owner
Name:
Immedica Pharma ABAddress:
Solnavägen 3H, 113 63 Stockholm, SE
Inventor
Name:
LOWE, DavidAddress:
Austin, TX 78735, US
Name:
ROWLINSON, Scott, W.Address:
Austin, TX 78746, US
Name:
ALTERS, SusanAddress:
Palo Alto, CA 94306, US
Name:
AGNELLO, GiuliaAddress:
Austin, TX 78751-5023, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662372092 PDate:
8.8.2016Country:
US
Number:
201762524286 PDate:
23.6.2017Country:
US
Classification
Categories:
A61K 38/50, A61K 39/00, C07K 16/28, C12N 9/78, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 16.8.2022
Expires: 7.9.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 5.9.2023
Expires: 7.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 26.8.2024
Expires: 7.9.2025
Payer: Zacco Denmark A/S
Number: 9
Paid: 24.6.2025
Expires: 7.9.2026
Payer: Zacco Denmark A/S